Skip to main content
. Author manuscript; available in PMC: 2014 Jun 26.
Published in final edited form as: Sci Transl Med. 2013 Sep 18;5(203):203ra125. doi: 10.1126/scitranslmed.3006061

Figure 2.

Figure 2

The distribution and characteristics of leukemia-associated phosphopeptides. (a, b) Euler diagrams depicting the distribution of HLA-B7-restricted phosphopeptides among different leukemias normal tissues (a) and within different B-cell malignancies (b). (c,d,f) Logoplots of residue frequency at each position of all 9mer HLA-B7 phosphopeptides (c); 9mer non-phosphorylated HLA-B7 peptides from the ImmuneEpitope database (d); and predicted HLA-B7 phosphopeptide binders with a pSer at position 4 (f). The position of phosphoserine for all B7-predicted binders (e).

HHS Vulnerability Disclosure